Tuğçe Canol Özbek

Tuğçe Canol Özbek

Auto-generated profile, based on publicly available information

Tuğçe Canol Özbek

Department of Child and Adolescent Psychiatry, Yalova State Hospital, Yalova, Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2025 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
MÖMutlu Muhammed Özbek
Mutlu Muhammed Özbek
EAEKİN ATAY
EKİN ATAY
DSDoğa Sevinçok
Doğa Sevinçok
HOHasan Can OZBAY
Hasan Can OZBAY
TÖTuğçe Canol Özbek
Tuğçe Canol Özbek
MCMehmet Akif CANSIZ
Mehmet Akif CANSIZ
We aimed to investigate the clinical characteristics of patients presenting to child and adolescent psychiatry outpatient clinics across different age groups, and to assess the prevalence of polypharmacy along with its associated factors within a clinical sample. A total of 569 patients with complete file data were included in the study. Psychiatric diagnoses were made by a clinician based on the diagnostic criteria stipulated in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. A detailed medical history was obtained for each patient, and their age, gender, education level, parents' age and education level, psychiatric diagnoses, and administered treatments were recorded for further analyses. Based on a review of the relationship between complaints at presentation and polypharmacy, irritability was more prevalent among polypharmacy users, while domestic problems were more prevalent in those who did not use polypharmacy. Based on our regression analysis; conduct disorder (CD) diagnosis (B=2.405, Exp [B]=11.079, p<0.001), age (B=0.127, Exp [B]=1.136, p=0.008), and any psychiatric comorbidity (B=4.761, Exp [B]=116.874, p<0.001) were the variables most frequently and significantly associated with polypharmacy independent of other variables. This study's results indicate that the presence of CD, age, and comorbid psychiatric diagnosis significantly increase the risk of polypharmacy. A better understanding of the factors that pave the way toward polypharmacy is critical to reduce unnecessary medication use in children and adolescents.

1 January 2020 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Closed access
TCTugce Canol
Tugce Canol
SSSermin Sapmaz
Sermin Sapmaz
AUAylin Uzun
Aylin Uzun
HKHasan Kandemir
Hasan Kandemir

31 March 2021 in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Closed access
PDF file
OBOznur Bilac
Oznur Bilac
TCTuğçe Canol
Tuğçe Canol
CKCanem Kavurma
Canem Kavurma
YIYetiş Işıldar
Yetiş Işıldar
SSSermin Yalın Sapmaz
Sermin Yalın Sapmaz
ISİlknur Sevi̇nc
İlknur Sevi̇nc
Giriş ve Amaç: Bu çalışmanın amacı Dikkat Eksikliği/Hiperaktivite Bozukluğu (DEHB) tanılı 11-17 yaş arası çocuk ve ergenlerin yeme tutumları ve uyku paternlerinin sağlıklı kontrollerle karşılaştırılarak incelenmesidir. Gereç ve Yöntemler: 11-17 yaş arası 35 DEHB tanılı çocuk ve ergen ile yaş ve cinsiyet olarak eşleştirilmiş herhangi bir psikopatolojisi olmayan 11-17 yaş arası 35 sağlıklı kontrol örneklemi oluşturdu. Her iki gruba sosyodemografik veri formu, Okul Çağı Çocukları için Duygulanım Bozuklukları ve Şizofreni Formu-Şimdi ve Yaşam boyu şekli Türkçe Uyarlaması (K-SADS-PL), Yeme Tutumu Testi (YTT), Düzey-2 Uyku Bozukluğu-6-17 Yaş Arası Çocuğun Ebeveyn Formu, Düzey-2 Uyku Bozukluğu-11-17 Yaş Arası Çocuk formu uygulandı. Bulgular: DEHB tanılı grup ve kontrol grubu arasında Düzey-2 Uyku Ölçeği Ebeveyn Formu ve YTT toplam puanlarında istatistiksel olarak anlamlı fark saptandı (p<0,001). Ebeveynleri tarafından uyku sorunu yaşadığı belirtilen çocukların yeme tutumları açısından da korele olacak şekilde sorun yaşadığı saptandı (p=0,018). Benlik saygısı çok sorunlu olan çocuklarda uyku ölçeği ebeveyn formu puanlarının istatistiksel olarak anlamlı olarak farklılaştığı saptandı (p=0,019). Sonuç: Çalışmamızın sonuçları uyku ve yeme sorunlarının DEHB tanılı çocuk ve ergenlerde sanıldığından yaygın olabileceğini, klinik değerlendirmelerde ayrıca göz önünde bulundurulması gerektiğini düșündürmektedir.

17 May 2024 in European Journal of Therapeutics
Verified
Journal Article
Open access
PDF file
TÖTuğçe Canol Özbek
Tuğçe Canol Özbek
MÖMutlu Muhammed Özbek
Mutlu Muhammed Özbek
In this letter to editor, while explaining the process leading to Capgras syndrome (CS), it will be tried to evaluate the psychodynamic, cognitive, neurological, and systemic factors as a result of the anamnesis and detailed examinations. Clinical aspects of the syndrome, psychopharmacologic agents to be used in the treatment process, and these agents' mechanisms of acts will be discussed. Y.B., a 16-year-old female patient, was admitted to our clinic by her family with complaints of restlessness, introversion, and voices in her ears. A psychiatric examination revealed that the patient had persecutory, referential, and somatic delusions and that her family was replaced with other families in her thought content. In the initial treatment of the patient, risperidone was preferred, and sertraline was added to her treatment after the regression in her symptoms was not at the desired level. CS is the most common type of misidentification syndrome. The patient believes that their parents, friends, or themselves have been replaced by people similar to them and may show strong hostility and distrust toward their environment. Although there is no single cause, biological and psychological factors are thought to play a role in its etiopathogenesis. When the literature is examined, it is seen that there are reports of CS in adults, and the number of case reports in adolescence is lower. It should be kept in mind that although rare, CS can be seen in the pediatric and young population and the addition of selective serotonin reuptake inhibitors may be beneficial in cases that do not respond to antipsychotic treatment.

7 August 2024 in European Journal of Therapeutics
Verified
Journal Article
Open access
PDF file
DSDoğa Sevinçok
Doğa Sevinçok
TÖTuğçe Canol Özbek
Tuğçe Canol Özbek
MÖMutlu Muhammed Özbek
Mutlu Muhammed Özbek
Objective: There is growing evidence that Cognitive Disengagement Syndrome (CDS) is a distinct construct, supported by both empirical research and clinical differentiation. CDS demonstrates a stronger association with the inattentive type of Attention Deficit Hyperactivity Disorder (ADHD-IA), compared to its correlation with hyperactivity/impulsivity symptoms. Several studies have identified a significant positive relationship between CDS and internalizing symptoms such as anxiety and depression. To our knowledge, no study has explored CDS in children with major depression (MD). In the present study, we compared children with MD but without ADHD to children with ADHD but without depression in terms of CDS. We examined whether children with MD would have greater CDS when compared to children with ADHD. Methods: Thirty-six adolescents with ADHD, and twenty-five adolescents with MD, aged 12 to 18 years old, were administered the Barkley Child Attention Scale (BCAS), Turgay's DSM-IV Based ADHD and Disruptive Behavior Disorders Screening Scale, and the Children’s Depression Rating Scale-Revised (CDRS-R). Results: The majority of the ADHD and MD groups were boys. The MD group had significantly higher BCAS scores than the ADHD group (U=287.0, p=0.016). In the ADHD group, the severity of BCAS scores was inversely correlated with ADHD-Hyperactivity/impulsivity scores (r=-0.681, p<0.001). In the MD group, there was a significant positive relationship between BCAS and CDRS scores (r= 0.493, p=0.012). Conclusions: The findings of this study highlight the transdiagnostic relevance of CDS by demonstrating its association with depression, independent of ADHD. This underscores the importance of considering CDS in the assessment and treatment of depression across various clinical contexts.